Continuous Glucose Monitoring Can Aid Hospital Patients

CGM monitoring for hospitalized diabetes patients can provide insight into insulin needs and reduce blood draws. Research at the American Diabetes Association sessions suggests most CGM readings fall within acceptable ranges, with potential integration into electronic health records. Studies show patients and nurses prefer CGM over traditional monitoring. Another study at Massachusetts General Hospital suggests…

Read More

What’s on the Agenda for MedCity INVEST Digital Health in Dallas?

MedCity’s annual INVEST Digital Health conference, happening in September in Dallas, will focus on AI and drug development, investment trends, consumer diagnostics, and digital health tools. The conference, at Pegasus Park, aims to support North Texas’ life sciences ecosystem. Discussions will cover issues like validating digital health tools, selling to employers, pharma’s use of AI,…

Read More

It’s time to put a health warning on social media

Dr Catherine Conlon highlights the mental health harms caused by social media, urging action to address the issue. Surveys show that many students feel unwelcome in school, with a rise in cyberbullying. The US Surgeon General calls for warning labels on social media platforms to address mental health risks. Parents, schools, and policymakers are urged…

Read More

T1D Exchange moves research to practice

Dr. Osagie Ebekozien, chief medical officer at T1D Exchange, discusses the organization’s efforts to translate research into practice in a video exclusive. T1D Exchange is focused on preparing practices for screening and preventing type 1 diabetes, improving outcomes in various populations, training clinicians and patients on diabetes technologies and therapies, and reaching out to primary…

Read More

Covid-19: Study sheds light on how some people avoid the disease

Scientists have discovered novel immune responses that explain how some people avoid getting COVID-19. High levels of a gene called HLA-DQA2 before exposure were associated with preventing sustained infection of SARS-CoV-2. The study involved 36 healthy adult volunteers who were administered the virus and monitored for immune responses. Those who cleared the virus effectively had…

Read More

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Novo Nordisk will present 34 abstracts at the upcoming 84th Scientific Sessions of the American Diabetes Association, focusing on their portfolio. The trials with semaglutide will assess benefits in diabetes, obesity, and cardiovascular disease. The data reflects the need for medicines that address multiple aspects of these interconnected conditions. Novo Nordisk aims to develop treatments…

Read More
error: Content is protected !!